Approximately 50%-70% of IMT cases exhibit ALK gene rearrangements or fusions, and about 50%-60% show positive ALK protein expression (3), whereas point mutations in the ALK gene are relatively uncommon. Here, ALK is linked to inflammatory myofibroblastic tumor.